NIPD Genetics is a European biotechnology company that designs, develops, and manufactures non-invasive genetic tests. NIPD Genetics was founded in 2010 as a spin-off from the Cyprus Institute of Neurology and Genetics to commercialize pioneering research work in the field of non-invasive prenatal diagnosis. NIPD Genetics leverages its proprietary genetic and bioinformatics methods to develop novel technologies for prediction and diagnosis of genetic disorders. NIPD Genetics provides the VERACITY non-invasive prenatal test for the detection of trisomies of chromosomes 21, 18, 13, aneuploidies of X and Y and microdeletions.